Physician profile
Michael Anthony Sauri
NPI 1003815424
$12,418.48
in general payments reported to CMS, 2019-2025
8 companies · $646 in 2025
The $646 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,183 · 2020: $1,924 · 2021: $81.02 · 2022: $17.73 · 2023: $639 · 2024: $3,928 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,055 · Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,055.00 |
| Food and Beverage | $157.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $5,183.00 | 2019 | |
| Novavax INC | $4,890.00 | 2023-2025 | Novavax Covid-19 Vaccine, Adjuvanted |
| Astrazeneca Pharmaceuticals LP | $1,065.00 | 2020-2023 | |
| Catalent Pharma Solutions, LLC | $1,012.50 | 2020 | |
| Gilead Sciences, INC. | $167.27 | 2021-2024 | |
| Sanofi Pasteur INC. | $53.02 | 2020-2022 | |
| Emergent Biosolutions INC. | $35.78 | 2023 | |
| Pfizer INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sauri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.